CDFI Industry Gets First-Ever Call Reporting System

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
[b]CDFI Industry Gets First-Ever Call Reporting System[/b]

PHILADELPHIA, PA, PA., April 15, 2014 (GLOBE NEWSWIRE) -- CARS Inc. announced today the availability of a call reporting system for community development financial institutions (CDFIs 1 ) to share quarterly performance data with their investors, representing a breakthrough for the industry. Previously, investors lacked the quarterly, standardized financial and impact data they need to understand individual CDFI and industry performance. The Citi Foundation is the lead philanthropic funder behind the development of the call reporting system, having provided more than $1.5 million in grant funding.

CARS Inc., the information service for community investing, also announced that two pioneering investors in CDFIs—Calvert Foundation and the Annie E. Casey Foundation—are leading the way to drive standardized reporting into the industry by becoming the first to use the CARS data service to monitor their CDFI investments.
 
The system will streamline investors' portfolio management, while alleviating the need for CDFIs to report financial performance in a variety of formats to many investors. Now CDFIs can report into one centralized database, similar to the call report system used by regulated depository institutions. It will also give new investor entrants, such as investment advisors, access to the type of Wall Street-quality data to which they are accustomed.
 
"CARS Inc. applauds the vision of both the investors and CDFIs that have opted-in to this system," said Paige Chapel, President & CEO of CARS Inc. "We believe this tool will help push CDFIs closer to becoming mainstream investment opportunities, in turn increasing positive financing options for underserved communities."
 
"Given the significant challenges facing underserved communities in the U.S. and the success CDFIs have had in deploying capital to support these communities, it is critical that the field identify new investor segments to infuse the sector with incremental capital," said Kristen Scheyder, Senior Program Officer at the Citi Foundation. "This initiative goes a long way to bringing greater transparency and standardization, making it easier for investors to understand, analyze, and invest in CDFIs. We are pleased to see the success of this project and expect its impact to be magnified as more investors join these early-adopters."
 
"After nearly twenty years of leadership in investing in CDFIs for social and financial returns, Calvert Foundation is a firm believer in the value of this tool for sharing CDFI impact and performance data with current and potential investors," said Catherine Godschalk, VP of Investments at Calvert Foundation. "CARS's one stop shop has already increased efficiencies for our CDFI partners by streamlining reporting requirements so they can focus on what they do best: creating positive impact in communities."
 
CARS Inc. expects to launch Version 2.0 of the system in late Q2 2014, which will include new features, such as a real-time peer analytics tool. In addition to the Citi Foundation, the Ford Foundation and the Annie E. Casey Foundation have provided funding for the additional development. Visit www.carsratingsystem.net for more information.

1  CDFIs are mission-driven financial institutions that make loans and investments to create economic opportunities in underserved markets of the U.S. 
 
About CARS Inc.
 
CARS Inc. is an information service for community investors, who invest to create economic opportunities in underserved markets. CARS Inc. provides data, analysis, and advisory services to support underwriting and monitoring of community development financial institutions (CDFIs). Its proprietary CDFI assessment tool (CARS®, the CDFI Assessment and Ratings System) helps investors evaluate opportunities that meet their impact goals and risk parameters. More than 50 of the nation's leading community investors—from AARP Foundation to Wells Fargo—currently subscribe to the CARS® Rating service.
 
About the Citi Foundation
 
The Citi Foundation works to promote economic progress in communities around the world and focuses on initiatives that expand financial inclusion. We collaborate with best-in-class partners to create measurable economic improvements that strengthen low-income families and communities. Through a "More than Philanthropy" approach, Citi's business resources and human capital enhance our philanthropic investments and impact. For more information, visit www.citifoundation.com . 
 
About Calvert Foundation
 
Calvert Foundation enables people to invest for social good. Through its flagship Community Investment Note, Calvert Foundation has raised $1 billion in investment from more than 13,000 investors to invest in hundreds of nonprofits and social enterprises worldwide. Investor dollars empower women, fund the construction of affordable housing, provide loans to small business owners, increase access to healthcare, and support fair trade and sustainable agriculture.
 
About the Annie E. Casey Foundation
 
The Annie E. Casey Foundation creates a brighter future for the nation's children by developing solutions to strengthen families, build paths to economic opportunity and transform struggling communities into safer and healthier places to live, work and grow. For more information, visit www.aecf.org .

Matt Royles CARS Inc. 267.233.5155

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 138

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 58

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 357

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Assessing TJX Companies Inc: Market Sentiment and Performance

Updated Category News Views 199

Understanding TJX Companies Inc's Market Dynamics TJX Companies Inc (NYSE: TJX) is currently navigating an intriguing landscape in the stock market, characterized by an increase in short interest. Notably, the short interest as a percentage of float has surged by 6.82% since the latest report, with approximately 15.68 million shares now sold short. This accounts for 1.41%...

Continue Reading
Refresco Teamsters Achieve Historic Contractual Victory

Updated Category News Views 337

Historic Contract Ratified by Teamsters Local 767 Members of Teamsters Local 767 have made headlines with their recent contract ratification that promises significant improvements for the workers of Refresco. An overwhelming majority of 93 percent voted in favor of this new agreement, showcasing the unity and commitment of the union members. Support for Employees The...

Continue Reading
MAP Medical and Metrix-Secure Team Up for Enhanced Healthcare

Updated Category News Views 133

MAP Medical Partners with Metrix-Secure for Enhanced Services MAP Medical has officially partnered with Metrix-Secure, a recognized leader in the medical supply industry. This collaboration empowers MAP Medical to serve as an authorized distributor, providing quality medical supply solutions to a wide array of healthcare facilities. Enhancing Patient Care with Reliable...

Continue Reading
Investors Show Interest in Unusual Options for Marriott

Updated Category News Views 153

Insights into Unusual Options Activity for Marriott International Recently, there has been a notable surge in bearish sentiment among investors concerning Marriott International (NASDAQ: MAR). This shift in attitude is essential for retail traders to understand as it may indicate changes in the market landscape. These trading patterns were identified through a publicly...

Continue Reading
Caribou Biosciences Investors Have Legal Avenues Available

Updated Category News Views 135

Opportunity for Investors of Caribou Biosciences For those who invested in Caribou Biosciences, Inc. (NASDAQ: CRBU), an exciting opportunity has emerged concerning potential legal claims. The Rosen Law Firm, recognized for its dedication to investor rights, is actively reminding purchasers of Caribou securities of their rights. If you bought securities between July 14,...

Continue Reading